Iain Stuart Email

sVP Clinical Development . Foamix Pharmaceuticals

Rehovot,

Location

LinkedIn

Current Roles

Employees:
39
Revenue:
$7.8M
About
Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology. Our clinical stage product candidates include FMX101, our novel minocycline foam for the treatment of moderate-to-severe acne, FMX103 for the treatment of moderate-to-severe rosacea.
Foamix Pharmaceuticals Address
520 U.S. Highway 22
Rehovot, null
Israel
Foamix Pharmaceuticals Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.